Harvard

Fewer than one-third of recently approved molecular-targeted cancer therapies demonstrated “substantial patient benefits,” according to data published in JAMA Oncology.

A national survey identified considerable unmet needs when it comes to training hematology/oncology fellows for careers in community-based practice.

Disparities in lupus ICU admission and renal outcomes between Black and white children are greater in children’s hospitals serving more Black patients, according to data published in Arthritis Care & Research.

Among patients who died of acute respiratory distress syndrome associated with SARS-CoV-2, the virus that causes COVID-19, heart tissues were damaged even when they were not directly affected by the virus, researchers reported.

Patients with higher baseline serum urate levels demonstrate increased recurrent gout hospitalization rates and subsequent risk for flare over 10 years of follow-up, according to data published in JAMA.

SAN FRANCISCO — For patients with idiopathic adhesive capsulitis or “frozen shoulder,” watchful waiting yielded similar outcomes with lower costs and decreased health care burden vs. physical therapy, according to presented results.

A computerized clinical decision support system intervention reduced patients’ mean systolic BP and increased prescriptions of multiple medications, a study in JAMA Internal Medicine showed.

Adoptive cellular therapies such as chimeric antigen receptor T-cell therapy have transformed the landscape of care for patients with relapsed or refractory hematologic malignancies.

Patients with a history of COVID-19 demonstrate a higher risk for new-onset autoimmune inflammatory rheumatic diseases, with greater infection severity linked to greater risk, according to data published in the Annals of Internal Medicine.

Testosterone replacement therapy alone did not lower risk for progression from prediabetes to diabetes or increase the likelihood of type 2 diabetes remission among men with hypogonadism, according to study data.